Patients with Guillain-Barré syndrome (GBS) face a rare and heterogeneous disorder of the peripheral nervous system that is often triggered by preceding infections and causes severe muscle weakness.
KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...
CONSHOHOCKEN, Pa., May 11, 2026 (GLOBE NEWSWIRE) -- May is GBS|CIDP Awareness Month and this year marks 110 years since the discovery of Guillain-Barré syndrome (GBS), which was first identified and ...
MUMBAI: BMC executive health officer Dr Daksha Shah said there is no cause for worry in Mumbai as Guillain-Barre Syndrome (GBS) is not a contagious disease. When TOI contacted her after a civic ...
DEAR DR. ROACH: I am a 73-year-old female with atrial fibrillation (AFib) who recently had a pacemaker implant and has been doing well since. I also have a thyroid gland disorder, and I’m taking daily ...
PUNE: The ninth casualty linked to Guillain-Barre Syndrome in Pune, a 34-year-old resident of Wagholi, showed symptoms that ...
Guillain-?Barr Syndrome is a rare condition in which a person's immune system attacks the peripheral nerves. People affected suffer from muscle weakness and paralysis. A research team led by ETH ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results